Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Vaccine|February 18, 2019
Optimization of a multivalent peptide vaccine for nicotine addictionDavid F Zeigler, Richard Roque, Christopher H CleggPlos One|June 2, 2017
Construction of an enantiopure bivalent nicotine vaccine using synthetic peptidesDavid F Zeigler, Richard Roque, Christopher H CleggPlos One|December 11, 2014
Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten CarrierKeith D Miller, Richard Roque, Christopher H CleggNPJ Vaccines|July 26, 2019
Epitope targeting with self-assembled peptide vaccinesDavid F Zeigler, Emily Gage, Richard Roque, et al.Plos One|February 20, 2014
GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenzaChristopher H Clegg, Richard Roque, Lucy A Perrone, et al.Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Adjuvant solution for pandemic influenza vaccine productionChristopher H Clegg, Richard Roque, Neal Van Hoeven, et al.Vaccines|August 28, 2025
SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody ResponsesJohnathan D Guest, Yi Zhang, Daniel Flores, et al.Plos One|July 5, 2013
Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma modelsCecile M Krejsa, Rick D Holly, Mark Heipel, et al.NPJ Vaccines|December 13, 2025
Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2Jason P Laliberte, Yingyun Cai, Tara Kenny, et al.Science Translational Medicine|January 25, 2022
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humansYueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, et al.Pageof 1